Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates
Added 10-11-21 03:04:02pm EST - “Merck & Co. and Ridgeback Biotherapeutics announced Monday they've requested emergency use authorization to the FDA for molnupiravir. COVID updates.” - News.yahoo.com
CLICK TO SHARE
Posted By TheNewsCommenter: From News.yahoo.com: “Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates”. Below is an excerpt from the article.
Pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics announced Monday they requested emergency use authorization to the Food and Drug Administration for molnupiravir, an antiviral drug that offers the promise that COVID-19 could soon be treated by a pill.
Molnupiravir, an orally ingested antiviral pill, is used to treat mild to moderate adult cases of COVID-19 that are at risk of worsening to severe COVID-19 or hospitalization, according to the companies. It was created by researchers at Emory University in Atlanta and is given as four pills taken twice a day for five days.
An interim analysis from a clinical trial found the antiviral medicine reduced the risk of hospitalization or death by approximately 50%.
Since early in the pandemic, public health officials have hoped for effective antivirals that could help prevent severe infection in people exposed to the SARS-CoV-2 virus. Several existing drugs were tested against the virus early on but shown to have no benefit for patients.
In June, the Biden administration allocated $3.2 billion toward the development of an antiviral, saying the drugs would be a crucial part of the fight against the virus.
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE